Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure

摘要

Cannabis use has been associated with psychosis and cognitive dysfunction. Some evidence suggests that the acute behavioral and neurocognitive effects of the main active ingredient in cannabis, (-)-trans-Delta 9-tetrahydrocannabinol (Delta 9-THC), might be modulated by previous cannabis exposure. However, this has not been investigated either using a control group of non-users, or following abstinence in modest cannabis users, who represent the majority of recreational users. Twenty-four healthy men participated in a double-blind, randomized, placebo-controlled, repeated-measures, within-subject, Delta 9-THC challenge study. Compared to non-users (N=12; 5 lifetime cannabis joints smoked), abstinent modest cannabis users (N=12; 24.5 +/- 9 lifetime cannabis joints smoked) showed worse performance and stronger right hemispheric activation during cognitive processing, independent of the acute challenge (all P=0.047). Acute Delta 9-THC administration produced transient anxiety and psychotomimetic symptoms (all P=0.02), the latter being greater in non-users compared to users (P=0.040). Non-users under placebo (control group) activated specific brain areas to perform the tasks, while deactivating others. An opposite pattern was found under acute (Delta 9-THC challenge in non-users) as well as residual (cannabis users under placebo) effect of Delta 9-THC. Under Delta 9-THC, cannabis users showed brain activity patterns intermediate between those in non-users under placebo (control group), and non-users under Delta 9-THC (acute effect) and cannabis users under placebo (residual effect). In non-users, the more severe the Delta 9-THC-induced psychotomimetic symptoms and cognitive impairments, the more pronounced was the neurophysiological alteration (all P=0.036). Previous modest cannabis use blunts the acute behavioral and neurophysiological effects of Delta 9-THC, which are more marked in people who have never used cannabis. (C) 2018 Elsevier B.V. and ECNP. All rights reserved.